Literature DB >> 12581000

Incidence of physician-diagnosed interstitial cystitis in Olmsted County: a community-based study.

R O Roberts1, E J Bergstralh, S E Bass, D J Lightner, M M Lieber, S J Jacobsen.   

Abstract

OBJECTIVE: To obtain community-based information about the incidence of interstitial cystitis, a chronic disabling condition of the bladder where knowledge is limited because there are no definitive diagnostic criteria. PATIENTS AND METHODS: All residents of Olmsted County, MN, USA who had received a physician-assigned diagnosis of interstitial cystitis between 1976 and 1996 were identified through the resources of the Rochester Epidemiology Project. The clinical findings at diagnosis and during the follow-up were ascertained from the community medical records for each study subject.
RESULTS: In all, 16 women and four men received a diagnosis of interstitial cystitis during the study period. The overall age- and sex-adjusted (95% confidence interval) incidence rate was 1.1 (0.6-1.5) per 100 000 population. The age-adjusted incidence rates were 1.6 per 100 000 in women and 0.6 per 100 000 in men (P = 0.04). The median (range) age at initial diagnosis was 44.5 (27-76) years in women and 71.5 (23-79) years in men (P = 0.26). The median number of episodes of care-seeking for symptoms before the diagnosis was one for women and 4.5 for men (P = 0.03). The median duration from the onset of symptoms until the first diagnosis was 0.06 and 2.2 years in women and men, respectively (P = 0.2).
CONCLUSIONS: These findings suggest that the incidence of interstitial cystitis in the community is extremely low. Although the gender difference may be real, the trend toward a later diagnosis in men than in women suggests a potential for missed diagnosis in men. This might explain some of the gender difference in the incidence of interstitial cystitis in men and women.

Entities:  

Mesh:

Year:  2003        PMID: 12581000     DOI: 10.1046/j.1464-410x.2003.04060.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

Review 1.  Functional and chronic anorectal and pelvic pain disorders.

Authors:  Adil E Bharucha; Emanuel Trabuco
Journal:  Gastroenterol Clin North Am       Date:  2008-09       Impact factor: 3.806

2.  Prevalence of painful bladder syndrome/interstitial cystitis-like symptoms in women: a population-based study in Korea.

Authors:  Jin Ho Choe; Hwancheol Son; Yun Seob Song; Joon Chul Kim; Jeong Zoo Lee; Kyu-Sung Lee
Journal:  World J Urol       Date:  2010-03-26       Impact factor: 4.226

3.  Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome.

Authors:  Ming-Huei Lee; Kun-Min Chang; Wen-Chen Tsai
Journal:  Int Urogynecol J       Date:  2018-03-12       Impact factor: 2.894

Review 4.  [Interstitial cystitis. Current aspects of diagnosis and therapy].

Authors:  A Loch; U Stein
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

Review 5.  [Interstitial cystitis. An important differential diagnosis].

Authors:  A van Ophoven; F Oberpenning
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

Review 6.  Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review.

Authors:  Jordan Dimitrakov; Kurt Kroenke; William D Steers; Charles Berde; David Zurakowski; Michael R Freeman; Jeffrey L Jackson
Journal:  Arch Intern Med       Date:  2007-10-08

7.  Unexplained association between cystitis glandularis and interstitial cystitis in females: a retrospective study.

Authors:  Wei Zhang; You-sheng Yao; Ming-en Lin; Wei-jie Xie; Wen-wei Pan
Journal:  Int Urogynecol J       Date:  2015-08-01       Impact factor: 2.894

8.  Incidence and clinical characteristics of interstitial cystitis in the community.

Authors:  Ronak Patel; Elizabeth A Calhoun; Richard T Meenan; Maureen C O'Keeffe Rosetti; Terry Kimes; J Quentin Clemens
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-02-12

9.  Interstitial cystitis: an enigmatic disorder of unclear aetiology.

Authors:  Dimitrios-Anestis Moutzouris; Harissios Vliagoftis; Matthew E Falagas
Journal:  NDT Plus       Date:  2008-02-27

10.  Analysis of Individual Differences in Vaccine Pharmacovigilance Using VAERS Data and MedDRA System Organ Classes: A Use Case Study With Trivalent Influenza Vaccine.

Authors:  Jingcheng Du; Yi Cai; Yong Chen; Yongqun He; Cui Tao
Journal:  Biomed Inform Insights       Date:  2017-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.